EZValidation is an example of how information technology is assisting in molecular diagnosis and helping to make costly research more efficient:
Life Technologies Launches EZValidation™ Online Tool for Clinical Laboratory Market
Many times the contribution from advances in one technology can have a profound impact on the profitability of another. For example, while it is great when a new compound is discovered that can cure a deadly disease, significant contributions can result from bringing the often cited "$1 billion and 10 years" investment to create a new drug down to say "$800 million and 8 years". This may not seem so dramatic as a cure for AIDS, but any improvement in the calculus of ROI on health care R&D serves to attract more investment dollars and increased potential for innovation. So, something as simple as simplifying work flows and coordinating clinical work can have profound benefit on the effort to improve the state of mankind as a result of that marginal dollar of investment that "tips" the odds toward a radical discovery.
Please note: The above entry is not a recommendation of Life Technologies as an investment. It is an illustration of how technologies reinforce each other. I currently hold a position in the stock of the above company. I also owned the predecessor companies, Invitrogen and Applied Biosciences, which merged into Life Technologies...it is a small world in many ways.